Nurse Practitioner in Mandeville, LA Accepting Medicare

48 Nurse Practitioner nurses found. Showing 41 - 48

Miss Sheri Michelle Berger, APRN, CPNP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1100 N Causeway Blvd, Suite 104, Mandeville, LA 70471 Phone: 985-674-2227    Fax: 985-674-1227

Mrs. Sarah Indian Smith, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 2011 Red Oak Ln, Mandeville, LA 70448 Phone: 772-332-8822

Melissa M Brown, ANP-C Nurse Practitioner - Adult Health Medicare: Accepting Medicare Assignments Practice Location: 3295 East Causeway Approach, Mandeville, LA 70448 Phone: 985-674-4015    Fax: 985-626-6956

Rebecca Willingham, PMHNP Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 23257 Kilgore St, Mandeville, LA 70471 Phone: 985-264-0312    Fax: 985-231-0213

Karen Riehm, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 2810 E Causeway Approach, Mandeville, LA 70448 Phone: 985-875-2340

Lacee Moak May, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 93 Tupelo Trce, Mandeville, LA 70471 Phone: 225-936-6799

Dr. Tyler Trenton Wansley, DNP, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 23515 Us-190, Mandeville, LA 70448 Phone: 985-626-6300

Mrs. Christina Young, CPNP Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1100 N Causeway Blvd Ste 104, Mandeville, LA 70471 Phone: 985-674-2227

News Archive

LDK378 compound well-tolerated in patients with ALK+ NSCLC

A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to crizotinib-the only approved ALK inhibitor. Results of this Novartis-sponsored sudy will be presented by a researcher from Fox Chase Cancer Center during the 2012 Annual Meeting of the American Society of Clinical Oncology on Sunday, June 3.

Cellegy ends phase III microbicide trial in Nigeria

Cellegy Pharmaceuticals on Monday announced that it has ended phase Phase III clinical trials in Nigeria on its microbicide Savvy, the Philadelphia Inquirer reports (Loyd, Philadelphia Inquirer, 8/29).

Scientists use mathematical concepts to analyze fMRI data

Research led by a Wayne State University Department of Mathematics professor is aiding researchers in Wayne State's Department of Psychiatry and Behavioral Neurosciences in analyzing fMRI data. fMRI is the preeminent class of signals collected from the brain in vivo and is irreplaceable in the study of brain dysfunction in many medical fields, including psychiatry, neurology, and pediatrics.

Protamine–heparin complex antibodies raise concerns

Almost a third of patients treated with protamine for heparin reversal during cardiopulmonary bypass develop antibodies to circulating protamine–heparin complexes, study findings suggest.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)